NEW YORK (
CHANGE IN RATINGS
(AAP - Get Report)
was upgraded at Deutsche Bank to buy from hold. $92 price target. Expectations are low, even though industry trends are improving, Deutsche Bank said.
Bed Bath & Beyond
was downgraded at Oppenheimer to hold from buy. Valuation call, based on a $78 price target, Oppenheimer said.
(BIDU - Get Report)
was upgraded at Morgan Stanley to overweight from equal-weight. $144.70 price target. Improved outlook and mobile monetization, Morgan Stanley said.
was downgraded at Robert Baird to neutral from outperform. Risk/reward is more balanced at current levels, Robert Baird said.
was upgraded at Credit Suisse to neutral from underperform. $48 price target. Company has a stronger foundation and can achieve its growth targets, Credit Suisse said.
was downgraded at Citigroup to neutral from buy and given a $21 price target. The turnaround has played out and CVG is more fairly valued, Citi said.
was upgraded at Robert Baird to outperform from neutral. $27 price target. Recent weakness in the stock has created a great entry point, Robert Baird said.
(DO - Get Report)
was downgraded at Williams Financial to hold from buy. $77 price target. Company is seeing higher downtime and utilization, in addition to higher expenses, Williams said.
was downgraded at DA Davidson to neutral from buy. $45 price target. Stock has made a big run, but earnings expectations are coming down, DA Davidson said.
was downgraded at Argus Research to hold from buy. Valuation call, as second quarter results are likely not sustainable, Argus said.
was downgraded at Keybanc to hold from buy. Valuation call, as the stock has enjoyed a big run, Keybanc said.
was downgraded at Oppenheimer to perform from outperform. Upside appears limited, barring an acceleration in the macro recovery, Oppenheimer said.
was downgraded at UBS to neutral from buy and given a $49 price target. Growth isn't materializing and visibility is limited, UBS said.